Labtician Ophthalmics and Laboratoires Théa Announce Joint Venture

Wednesday, November 22 2017 | 00 h 00 min | News

Labtician Ophthalmics Inc. of Oakville, Canada, and Laboratoires Théa of Clermont-Ferrand, France, today announced the launch of Labtician Théa, Canada’s new leader in the preservative-free management of glaucoma, dry eye disease and lid hygiene.

Though Labtician Théa is new to Canada, a rich history of innovation runs deep within its two founding companies. Labtician Ophthalmics has 60 years of experience in bringing innovation to practice for eye care professionals in Canada. Laboratoires Théa, with 150 years of history in eye care, is now Europe’s largest family-owned ophthalmology company, having built a solid reputation as the pioneer and leader in the development of preservative-free eye care treatments.

The joint venture will leverage the strengths of both organizations to focus exclusively on helping Canadian optometrists and ophthalmologists build their practices and preserve eye health for their patients. In doing so, Labtician Théa aims to become an essential partner to Canadian optometrists and ophthalmologists, delivering solutions-focused support, backed by dedicated and experienced representatives, comprehensive education and practice management programs and highly responsive practice management specialists.

“This agreement represents a major win for Canadian eye care professionals and their patients,” says Mark Smithyes, President of Labtician Théa. He continued, “Combining Théa’s rich pipeline of preservative-free treatments, which are already the standard of care in Europe, with Labtician’s proven sales, distribution and service expertise, Canadian optometrists and ophthalmologists will now have the very best options available to improve their patients’ eye health.”

Click here for more information.